Our aim was to review clinical outcome and patient satisfaction after cataract surgery to obtain spectacle independence following multifocal intraocular lens (IOL) implantation. A prospective case-series study was designed to evaluate the safety and efficacy of the Hanita FullRange pseudophakic multifocal intraocular lens in patients with programmed cataract surgery, performed between October 2017 and May 2018, with follow-up after 12 months. Manifest refraction spherical equivalent (SE), SE refractive accuracy, uncorrected distance (UDVA), intermediate (UIVA) and near visual acuity (UNVA) and a binocular defocus curve were evaluated. In addition, a short “satisfaction questionnaire” was developed.
Hanita Lenses MedTalks at the ESCRS 2024
Missed the Hanita Lenses booth at ESCRS 2024? Don’t worry! Access exclusive MedTalks presentations from top cataract surgeons like Prof. Ehud Assia and Prof. Roberto Bellucci. Discover insights into Hanita’s cutting-edge technologies, including the world’s first pentafocal IOL.